QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Innovative medicines require an innovative approach
In this text, Mary Rosenzweig, Country director Denmark at Quantify Research, gives her perspectives on the changing landscapes in market access and real-world evidence in Denmark and the keys to successful value demonstration of new innovative medicines.
Innovative medicines require an innovative approach
As the costs of healthcare rise globally, Denmark is working hard to keep healthcare spending under tight control in unison with payers everywhere. Hence, great attention is given […]
Quantify’s Olivia Ernstsson to give online presentation of her PhD thesis
Quantify’s Olivia Ernstsson will give an online presentation of her PhD thesis ‘Making use of patient-reported outcome measures in health care: the case of EQ-5D in the Swedish national quality registries’, on the 15th of October, at 14.00–15.30. The presentation will be part of the Network for Health Economics, NHE, organized by the SBU, Statens beredning för medicinsk och social utvärdering (Swedish Agency for Health Technology Assessment and […]
Martin Grøvdal Thoresen joins Quantify!
Last week we were thrilled to welcome Martin Grøvdal Thoresen to our Norwegian Office as our new Project Leader. Martin is an educated health economist, specialized in economic evaluation in healthcare from the Joint EU-Hem degree. He has in-depth knowledge and experience within market access and health economics from Norway. Prior to joining Quantify, he has dealt with the relevant governmental bodies and has accrued an understanding of the […]
Lingjing Chen joins Quantify!
Today we proudly introduce Lingjing Chen who recently joined Quantify as a Senior Project Leader. For the past 11 years, Lingjing has worked with Real-World Evidence research based on Swedish health data at Karolinska Institutet. Her research focus has been on cancer survivorship, trying to understand the relationships between cancer, treatment, and long-term survival among cancer patients. Besides research, she has been very active in teaching at master and […]